TWi Biotechnology, Inc (TWiB) is a clinical stage biopharmaceutical company based in Taipei, Taiwan specializing in the development of repositioned drugs for unmet medical needs, especially in rare diseases associated with inflammation or inflammatory conditions.
Company Details
- Employees
- 18
- Founded
- 2010
- Address
- 8f, No.41, Ln.221, Kang Chien Rd.,, Taipei,114,taiwan, Province Of China
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Keywords
- Epidermolysis Bullosa Simplex, Granuloma Annulare, Drug repositioning, Rare Disease, Dermatologic Disease.
- HQ
- Taipei
Twi Biotechnology 安成生物科技股份有限公司 Questions
Twi Biotechnology 安成生物科技股份有限公司's website is https://www.twibiotech.com/website
Twi Biotechnology 安成生物科技股份有限公司's LinkedIn profile is https://tw.linkedin.com/company/twi-biotechnology
Twi Biotechnology 安成生物科技股份有限公司 has
18 employees.
View email and phone details for 18
employees at Twi Biotechnology 安成生物科技股份有限公司.
Twi Biotechnology 安成生物科技股份有限公司's industry is
Biotechnology Research
Twi Biotechnology 安成生物科技股份有限公司's top competitors are
Obi Pharma,
Annji Pharmaceutical Co., Ltd.,
Global Bio & Investment Monthly,
Astrazeneca Taiwan,
Ahead Medicine,
Tca (Taiwan Cdmo Alliance),
Msd Taiwan,
Oneness Biotech Co Ltd,
Clinuvel Pharmaceuticals Ltd,
大人學.
Twi Biotechnology 安成生物科技股份有限公司's categories are Biotechnology Research
Twi Biotechnology 安成生物科技股份有限公司's founding year is 2010
